During the past decade, Northeastern Ontario Regional Cancer Centre, Sudbury conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 19 clinical trials were completed, i.e. on average, 475% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northeastern Ontario Regional Cancer Centre, Sudbury" #1 sponsor was "Radiation Therapy Oncology Group" with 40 trials, followed by "NCIC Clinical Trials Group" with 21 trials sponsored, "Ontario Clinical Oncology Group (OCOG)" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northeastern Ontario Regional Cancer Centre, Sudbury" #1 collaborator was "National Cancer Institute (NCI)" with 54 trials as a collaborator, "NCIC Clinical Trials Group" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator, "North Central Cancer Treatment Group" with 7 trials as a collaborator and "NRG Oncology" with 6 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Northeastern Ontario Regional Cancer Centre, Sudbury" are "Breast Cancer" (17 trials), "Lung Cancer" (12 trials), "Head and Neck Cancer" (11 trials), "Prostate Cancer" (10 trials) and "Metastatic Cancer" (5 trials). Many other conditions were trialed in "Northeastern Ontario Regional Cancer Centre, Sudbury" in a lesser frequency.

Most popular intervention types in "Northeastern Ontario Regional Cancer Centre, Sudbury" are "Drug" (68 trials), "Radiation" (45 trials), "Procedure" (19 trials), "Biological" (14 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (31 trials), "cisplatin" (12 trials), "paclitaxel" (10 trials), "conventional surgery" (9 trials) and "filgrastim" (8 trials). Other intervention names were less common.

The vast majority of trials in "Northeastern Ontario Regional Cancer Centre, Sudbury" are 64 trials for "All" genders, 20 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Northeastern Ontario Regional Cancer Centre, Sudbury". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 83 completed trials in Northeastern Ontario Regional Cancer Centre, Sudbury, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Northeastern Ontario Regional Cancer Centre, Sudbury, 9 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".